Related Experiment Videos
Insights
Hypertension alters cerebral blood flow (CBF) autoregulation, increasing resistance and shifting limits. Lowering blood pressure too rapidly can cause ischemic damage in hypertensive patients.
Area of Science:
- Neurology
- Cardiovascular Science
- Pharmacology
Background:
- Hypertension significantly impacts cerebral blood flow (CBF) regulation.
- Increased cerebrovascular resistance in hypertension raises the pressure thresholds for CBF autoregulation.
- Structural changes in cerebral vessels contribute to altered autoregulation, protecting against high pressure but increasing ischemia risk at lower pressures.
Purpose of the Study:
- To analyze the effects of hypertension on cerebral blood flow (CBF) autoregulation.
- To categorize antihypertensive drugs based on their impact on cerebral circulation and autoregulation.
- To understand the mechanisms by which hypertension-induced vascular changes affect brain perfusion.
Main Methods:
- Review of existing literature on cerebral blood flow (CBF) and hypertension.
- Analysis of the physiological mechanisms of cerebral autoregulation.
- Classification of antihypertensive agents by their direct and indirect effects on cerebral vasculature.
Main Results:
- Hypertension shifts the lower and upper limits of cerebral blood flow (CBF) autoregulation to higher pressure levels due to increased cerebrovascular resistance.
- Adaptive changes, like vessel thickening, protect against high pressure but risk ischemia during rapid blood pressure reduction.
- Antihypertensive drugs are categorized into four groups based on their effects on CBF and autoregulation.
Conclusions:
- Understanding altered cerebral blood flow (CBF) autoregulation in hypertension is critical for safe blood pressure management.
- Rapid reduction of blood pressure in hypertensive individuals can lead to cerebral ischemia if it falls below the shifted autoregulation lower limit.
- The classification of antihypertensive drugs provides insight into their potential impact on brain perfusion during treatment.
Abstract:
The most important aspect of cerebral blood flow (CBF) in hypertension is the change that occurs in CBF autoregulation: increased cerebrovascular resistance causes the lower and upper limits of CBF autoregulation to be at higher pressure levels. The mechanism seems to be mainly structural thickening and luminal narrowing of cerebral resistance vessels. These adaptive changes, while protecting the brain against high intravascular pressure, render the brain more susceptible to ischemia at low blood pressure. An obvious consequence of the shift in the lower limit of CBF autoregulation in hypertension is that if the hypertensive patient's blood pressure is lowered acutely to "normal" levels, the pressure is below the patient's lower limit of autoregulation and ischemic damage may result. Basically, antihypertensive drugs can be placed into four groups as regards their effects on the cerebral circulation. First are the drugs without any direct effect: in this case, CBF remains constant until pressure reaches the lower limit of autoregulation and then decreases with any further pressure decrease. Diazoxide is in this category. Second are the drugs that directly dilate the small resistance levels in such a way that CBF is higher than normal at every pressure including pressures below the lower limit of autoregulation. However, perfusion may be uneven and autoregulation may be lost; an example of this kind of drug is dihydralazine. Third are the drugs which by alpha-or ganglion-blockade prevent the sympathetic vasoconstriction of large cerebral arteries (pial and larger), which can compromise CBF during a fall in blood pressure and hence shift the lower limit of autoregulation to a higher pressure than during blockade.(ABSTRACT TRUNCATED AT 250 WORDS)